Steven H. Holtzman - Jun 25, 2025 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role
Director
Signature
/s/ Josh Mandel-Brehm, as Attorney-in-Fact
Stock symbol
CAMP
Transactions as of
Jun 25, 2025
Transactions value $
$0
Form type
4
Date filed
6/27/2025, 04:02 PM
Previous filing
Oct 15, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Holtzman Steven H Director C/O CAMP4 THERAPEUTICS CORPORATION, ONE KENDALL SQ., BLDG 1400 WEST, 3RD FL., CAMBRIDGE /s/ Josh Mandel-Brehm, as Attorney-in-Fact 2025-06-27 0001300247

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAMP Stock Option (Right to Buy) Award $0 +9K $0.00 9K Jun 25, 2025 Common Stock 9K $1.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option vest in their entirety on the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders, subject to continued service to the issuer's board of directors through the applicable vesting date.